|

Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy

RECRUITINGN/ASponsored by State University of New York at Buffalo
Actively Recruiting
PhaseN/A
SponsorState University of New York at Buffalo
Started2026-06-15
Est. completion2027-02-01
Eligibility
Age18 Years – 60 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07641361

Summary

This is a 17 - week study consisting of a one - week run - in period and a 16 - week intervention. The 16 - week pilot interventions aims to increase hydration in those beginning GLP - 1 RA therapy. Investigators aim to increase hydration to potentially decrease side effect severity, amount of side effects, and drug discontinuation associated with GLP - 1 RA therapy. The investigators are piloting to assess feasibility and preliminary efficacy of the intervention through examining participant retention, participant feedback, researcher and participant adherence to protocols, impact on hydration biomarkers, and participant reported GLP - 1 RA side effects.

Eligibility

Age: 18 Years – 60 YearsHealthy volunteers accepted
Inclusion Criteria:

* Adults aged 18-60
* Recently prescribed a GLP-1RA (within one week of prescription)
* Fluent in English
* Willing to complete the study protocol

Exclusion Criteria:

* Children and adults \> 60 years of age
* Those not taking a GLP-1RA
* Those who have been on a GLP-1RA longer than one week
* Not fluent in English
* Those who are pregnant or planning on becoming pregnant during the duration of the study
* Unwilling to comply with study protocol
* People with cardiac implants

Conditions6

DehydrationDiabetesObesity & OverweightObesity Type 2 Diabetes MellitusType 2 DiabetesType 2 Diabetes (Adult Onset)

Locations1 site

State University of New York at Buffalo, South Campus
Buffalo, New York, 14214
Hannah E Kolpack, BS(716) 829 - 5820hkolpack@buffalo.edu

Find trials near these locations

All trials in New York

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.